Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Eur J Pharm Biopharm ; 191: 68-77, 2023 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-37625656

RESUMO

Characterising the small intestine absorptive membrane is essential to enable prediction of the systemic exposure of oral formulations. In particular, the ontogeny of key intestinal Drug Metabolising Enzymes and Transporter (DMET) proteins involved in drug disposition needs to be elucidated to allow for accurate prediction of the PK profile of drugs in the paediatric cohort. Using pinch biopsies from the paediatric duodenum (n = 36; aged 11 months to 15 years), the abundance of 21 DMET proteins and two enterocyte markers were quantified via LC-MS/MS. An established LCMS nanoflow method was translated to enable analysis on a microflow LC system, and a new stable-isotope-labelled QconCAT standard developed to enable quantification of these proteins. Villin-1 was used to standardise abundancy values. The observed abundancies and ontogeny profiles, agreed with adult LC-MS/MS-based data, and historic paediatric data obtained via western blotting. A linear trend with age was observed for duodenal CYP3A4 and CES2 only. As this work quantified peptides on a pinch biopsy coupled with a microflow method, future studies using a wider population range are very feasible. Furthermore, this DMET ontogeny data can be used to inform paediatric PBPK modelling and to enhance the understanding of oral drug absorption and gut bioavailability in paediatric populations.


Assuntos
Proteômica , Espectrometria de Massas em Tandem , Adulto , Humanos , Criança , Cromatografia Líquida/métodos , Proteômica/métodos , Espectrometria de Massas em Tandem/métodos , Proteínas de Membrana Transportadoras/metabolismo , Duodeno/metabolismo
2.
J Pharm Biomed Anal ; 216: 114798, 2022 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-35561436

RESUMO

This study describes the first reported development of a rapid, generic gradient Ultra-High Performance Liquid Chromatography (UHPLC) methodology with targeted triple quadrupole MS/MS using electrospray positive ionisation to detect and unambiguously confirm the identity of 33 substituted 1, 2-diarylethamine (or diphenidine) derivatives in solid drug samples. The in-house synthesised library included a range of derivatives possessing either electron donating/withdrawing substituents, commonly included in combinatorial libraries, of varying size and lipophilicity on the phenyl ring. These test probes were used to investigate if their order of elution and that of their regioisomers were dependent on the position and type of the substituent on the phenyl ring. In addition, investigations into the retention mechanism of the diphenidines under reverse-phase UHPLC conditions were undertaken. Common adulterants found within seized bulk samples were assessed to prove that the methodology was specific, and the developed UHPLC-MS/MS (tG = 10 min) protocol was applied to confirm the identity of the psychoactive components within four seized bulk samples provided by law enforcement.


Assuntos
Piperidinas , Espectrometria de Massas em Tandem , Cromatografia Líquida de Alta Pressão/métodos , Psicotrópicos/química , Espectrometria de Massas em Tandem/métodos
3.
MethodsX ; 5: 149-158, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30622913

RESUMO

Anticoagulant rodenticide (AR) products are used globally to control rodent pests in domestic, urban, agricultural and industrial environments. However, there is a substantial volume of evidence that non-target vertebrate wildlife i.e. predators and scavengers in particular and other animals, are vulnerable to contamination via direct or indirect routes of exposure. The determination of multiple AR residues in liver tissue samples that can range from remnants of a small bird of prey liver to an intact liver from a large mammal is complicated as residue levels encountered can vary considerably too. So, the utilisation of ultra-sensitive systems has to be carefully considered in order to allow routine application of the method to all sample compositions presented for analysis. The UHPLC-MSMS method described now: •permits quantitative analysis of ultra-low levels of multiple-residues (0.0025-1 mg kg-1) in a single experiment.•uses the same U(H)PLC column for the determination of AR and multiple-pesticide residue in similar specimens.•allows higher sample throughput due to shaking rather than tumbling of samples during the extraction procedure.

4.
J Biol Chem ; 286(16): 14315-23, 2011 Apr 22.
Artigo em Inglês | MEDLINE | ID: mdl-21324911

RESUMO

RNA turnover is an essential element of cellular homeostasis and response to environmental change. Whether the ribonucleases that mediate RNA turnover can respond to cellular metabolic status is an unresolved question. Here we present evidence that the Krebs cycle metabolite citrate affects the activity of Escherichia coli polynucleotide phosphorylase (PNPase) and, conversely, that cellular metabolism is affected widely by PNPase activity. An E. coli strain that requires PNPase for viability has suppressed growth in the presence of increased citrate concentration. Transcriptome analysis reveals a PNPase-mediated response to citrate, and PNPase deletion broadly impacts on the metabolome. In vitro, citrate directly binds and modulates PNPase activity, as predicted by crystallographic data. Binding of metal-chelated citrate in the active site at physiological concentrations appears to inhibit enzyme activity. However, metal-free citrate is bound at a vestigial active site, where it stimulates PNPase activity. Mutagenesis data confirmed a potential role of this vestigial site as an allosteric binding pocket that recognizes metal-free citrate. Collectively, these findings suggest that RNA degradative pathways communicate with central metabolism. This communication appears to be part of a feedback network that may contribute to global regulation of metabolism and cellular energy efficiency.


Assuntos
Escherichia coli/enzimologia , Regulação Enzimológica da Expressão Gênica , Polirribonucleotídeo Nucleotidiltransferase/metabolismo , Sítio Alostérico , Ácido Cítrico/química , Clonagem Molecular , Cristalografia por Raios X/métodos , Deleção de Genes , Metabolômica/métodos , Metais/química , Modelos Químicos , Mutagênese , Análise de Sequência com Séries de Oligonucleotídeos , Polímeros/química , Ligação Proteica
5.
Mol Biosyst ; 5(12): 1913-24, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20023725

RESUMO

There is an increased need to develop robust cellular model systems which could replace or reduce the need for animals in toxicological testing. Current in vitro strategies for genotoxicity testing suffer from a high irrelevant positive rate, requiring the need for the development of new in vitro tools. Saccharomyces cerevisiae is used widely to study DNA damage and repair, and a high-throughput green fluorescent protein based assay has been developed to detect genotoxic-induced DNA damage. In this study a combined high resolution (1)H NMR spectroscopy and gas chromatography mass spectrometry based metabolomic approach has been used to monitor and distinguish different genotoxic compounds from other types of toxic lesion using the multivariate classification tool partial least squares-discriminate analysis (PLS-DA). The metabolic profiles of extracts of yeast (W303alpha strain) readily distinguished the individual toxins from control cells across 22 different treatments. In addition, these metabolic profiles also demonstrated dose and time responses for selected compounds (methyl methane sulfonate and nocodazole). Finally, predictive models were built for distinguishing the genotoxic carcinogens from the control group according to the metabolic profile of the cell culture media.


Assuntos
Metabolômica/métodos , Mutagênicos/farmacologia , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/metabolismo , Biologia de Sistemas/métodos , Alquilantes/farmacologia , Extratos Celulares/química , Proliferação de Células/efeitos dos fármacos , Meios de Cultura/química , Meios de Cultura/metabolismo , Relação Dose-Resposta a Droga , Cromatografia Gasosa-Espectrometria de Massas , Análise dos Mínimos Quadrados , Modelos Biológicos , Análise Multivariada , Nocodazol/farmacologia , Ressonância Magnética Nuclear Biomolecular , Análise de Componente Principal , Saccharomyces cerevisiae/genética
6.
Metabolomics ; 5(3): 363-374, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20208976

RESUMO

Previous studies have shown that a combination of weight loss and fish oil supplementation reduce cardiovascular disease and diabetes risks by increasing adiponectin and reducing triacylglyceride concentrations, while weight loss alone significantly improves insulin sensitivity and reduces inflammation. Here, a metabolomic approach, using a combination of (1)H-Nuclear Magnetic Resonance spectroscopy, and gas and liquid chromatography and mass spectrometry, was employed to elucidate the metabolic changes in blood plasma following weight loss and fish oil supplementation. The intervention study was conducted over 24 weeks, with 93 female subjects randomised to one of three groups. Two groups followed a 12-week weight loss program, followed by a 12-week weight maintenance period and were randomised to fish or placebo oil capsules; a control group did not follow the weight loss program and were given placebo oil capsules. Lipid profiles changed dramatically upon fish oil intake and subtly across the two weight loss groups. While the fish oil supplementation increased the proportion of various phospholipid species, previously reported reductions in total triacylglycerides (TAGs) upon fish oil intake were shown to be driven by a reduction in a specific subset of the measured TAGs. This remodelling of triglycerides may represent further beneficial effects of fish oil supplementation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11306-009-0161-7) contains supplementary material, which is available to authorized users.

7.
Structure ; 16(12): 1860-72, 2008 Dec 10.
Artigo em Inglês | MEDLINE | ID: mdl-19081062

RESUMO

The pyruvate dehydrogenase multienzyme assembly (PDH) generates acetyl coenzyme A and reducing equivalents from pyruvate in a multiple-step process that is a nexus of central metabolism. We report crystal structures of the Geobacillus stearothermophilus PDH E1p subunit with ligands that mimic the prereaction complex and the postdecarboxylation product. The structures implicate residues that help to orient substrates, nurture intermediates, and organize surface loops so that they can engage a mobile lipoyl domain that receives the acetyl group and shuttles it to the next active site. The structural and enzymatic data suggest that H128beta performs a dual role: first, as electrostatic catalyst of the reaction of pyruvate with the thiamine cofactor; and second, as a proton donor in the second reaction of acetyl group with the lipoate. We also identify I206alpha as a key residue in mediating the conformation of active-site loops. We propose that a simple conformational flip of the H271alpha side chain assists transfer of the acetyl group from thiamine cofactor to lipoyl domain in synchrony with reduction of the dithiolane ring.


Assuntos
Geobacillus stearothermophilus/enzimologia , Complexo Piruvato Desidrogenase/metabolismo , Acetilcoenzima A/biossíntese , Acetilcoenzima A/genética , Sequência de Aminoácidos , Sítios de Ligação/genética , Catálise , Geobacillus stearothermophilus/genética , Geobacillus stearothermophilus/metabolismo , Modelos Biológicos , Modelos Moleculares , Mutação , Ligação Proteica/genética , Estrutura Quaternária de Proteína/genética , Estrutura Secundária de Proteína/genética , Estrutura Terciária de Proteína/genética , Complexo Piruvato Desidrogenase/química , Complexo Piruvato Desidrogenase/genética , Relação Estrutura-Atividade , Especificidade por Substrato/genética
8.
Artigo em Inglês | MEDLINE | ID: mdl-18458005

RESUMO

In recent years, lipidomics or lipid profiling, an extension of metabolomics where the lipid complement of a cell, tissue or organism is measured, has been the recipient of increasing attention as a research tool in a range of diverse disciplines including physiology, lipid biochemistry, clinical biomarker discovery and pathology. The advancement of the field has been driven by the development of analytical technologies, and in particular advances in liquid chromatography mass spectrometry and chemometric methods. In this review, we give an overview of the current methods with which lipid profiling is being performed. The benefits and shortcomings of mass spectrometry both in the presence and absence of chromatographic separation techniques such as liquid-, gas- and thin layer chromatography are explored. Alone these techniques have their limitations but through a combination many of the disadvantages may be overcome providing a valuable analytical tool for a variety of disease processes.


Assuntos
Biologia Computacional/métodos , Metabolismo dos Lipídeos , Cromatografia Líquida/métodos , Cromatografia em Camada Fina/métodos , Cromatografia Gasosa-Espectrometria de Massas/métodos , Espectrometria de Massas/métodos
9.
Biomark Med ; 1(4): 575-82, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20477375

RESUMO

The functional genomic approach of metabolomics consists of the application of a global analytical tool to profile metabolism in a cell, tissue or organism. The most popular analytical tools include high-resolution (1)H nuclear magnetic resonance spectroscopy and mass spectrometry. Metabolomics is high throughput and relatively cheap on a per-sample basis and, hence, ideal for collecting large data sets. Biofluids are being used to follow the progression of obesity both in animal models and humans, while tissue extracts can be examined to probe the mechanisms responsible for these biofluid changes. Given these benefits and the results already produced in the field, metabolomics will play an increasing role in understanding the progression of obesity.

10.
Science ; 306(5697): 872-6, 2004 Oct 29.
Artigo em Inglês | MEDLINE | ID: mdl-15514159

RESUMO

Thiamine diphosphate (ThDP) is used as a cofactor in many key metabolic enzymes. We present evidence that the ThDPs in the two active sites of the E1 (EC 1.2.4.1) component of the pyruvate dehydrogenase complex communicate over a distance of 20 angstroms by reversibly shuttling a proton through an acidic tunnel in the protein. This "proton wire" permits the co-factors to serve reciprocally as general acid/base in catalysis and to switch the conformation of crucial active-site peptide loops. This synchronizes the progression of chemical events and can account for the oligomeric organization, conformational asymmetry, and "ping-pong" kinetic properties of E1 and other thiamine-dependent enzymes.


Assuntos
Geobacillus stearothermophilus/enzimologia , Piruvato Desidrogenase (Lipoamida)/química , Piruvato Desidrogenase (Lipoamida)/metabolismo , Complexo Piruvato Desidrogenase/química , Complexo Piruvato Desidrogenase/metabolismo , Tiamina Pirofosfato/metabolismo , Substituição de Aminoácidos , Sítios de Ligação , Catálise , Cristalografia por Raios X , Di-Hidrolipoil-Lisina-Resíduo Acetiltransferase , Concentração de Íons de Hidrogênio , Interações Hidrofóbicas e Hidrofílicas , Cinética , Modelos Moleculares , Mutação , Fosforilação , Conformação Proteica , Dobramento de Proteína , Estrutura Quaternária de Proteína , Estrutura Terciária de Proteína , Subunidades Proteicas/química , Subunidades Proteicas/metabolismo , Prótons , Piruvato Desidrogenase (Lipoamida)/genética , Ácido Pirúvico/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA